Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While MOTS-c improves insulin sensitivity, enhances glycolysis, reduces oxidative stress, and shows protective effects in models of metabolic syndrome, aging, and ischemia-reperfusion injury8135146, TB-500 is studied for enhancing musculoskeletal and cardiac repair, wound healing, and promoting cell migration and differentiation via actin cytoskeleton remodeling21255.
While MOTS-c works as a 16-amino-acid mitochondrial-derived peptide that translocates to the nucleus under metabolic stress and regulates glucose and lipid metabolism largely via activation of AMPK and modulation of mTOR and folate-cycle–linked pathways854140146, TB-500 is a synthetic peptide comprising the LKKTETQ actin-binding motif of thymosin beta-4 that binds G-actin, sequesters actin monomers, and promotes cell migration, angiogenesis, and tissue repair1255.
MOTS-c
TB-500
Binds monomeric actin (G-actin) rather than a classical cell-surface receptor, modulating actin polymerization at barbed and pointed ends55
MOTS-c
MT-RNR1
TB-500
TMSB4X
MOTS-c and TB-500 are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: MOTS-c is more often discussed in the realm of Metabolic and endocrine and Aging and longevity, whereas TB-500 is more often associated with the realm of Musculoskeletal health and Cardiovascular health. Their biological logic is quite different: MOTS-c is a gene expression modulator, whereas TB-500 is a signaling modulator and a growth factor mimetic. MOTS-c has a more mitochondrial-encoded origin, while TB-500 is closer to synthetic analog background and both are still best understood as being in Preclinical development. Their sequence patterns also diverge, with MOTS-c showing hydrophobic domain features and TB-500 showing protein-mimetic sequence features.